EMAIL DETAILS

Would this be the same GS banking team that would be pitching to take Counsyl public? Or is there a biotech team? What category does Counsyl fall under at GS?

--------------------
Neil Callahan
Rosemont Seneca
917-945-9516

> On Mar 3, 2014, at 9:47 PM, John DeLoche <jdeloche@rosemontseneca.com> wrote:
>
> Understood, thanks. Very good pres re current valuation environment. Julia introduced me to a GS healthcare banker. I have a call with him next week. Will ask what companies in this space are on their IPO radar and see if he mentions AW. Will then intro them to Counsyl as their banking team has yet to meet Counsyl (primarily due to Ramji's lack of interest in meeting bankers).
>
> Best,
>
> John
> Sent from my iPhone
>
>> On Mar 3, 2014, at 3:09 PM, Hunter Biden <hbiden@rosemontseneca.com> wrote:
>>
>> Pls do not share. See note below.
>>
>> RHB
>> 202.333.1880
>>
>> Begin forwarded message:
>>
>>> From: Paul Rowan <perowan@gmail.com>
>>> Date: March 3, 2014 at 6:01:43 PM EST
>>> To: Hunter 1/7/14 <hbiden@rosemontseneca.com>
>>> Subject: Fwd: GS on pdf
>>> H:
>>> Please keep this within your group - we don't want this getting back to GS
>>> PR
>>>
>>> Sent from my iPad
>>>
>>> Begin forwarded message:
>>>
>>>> From: GMAIL <rubioparis@gmail.com>
>>>> Date: February 19, 2014 at 4:44:29 PM EST
>>>> To: "Paul Rowan" <perowan@gmail.com>
>>>> Subject: GS on pdf
>>>> Reply-To: GMAIL <rubioparis@gmail.com>
>>>> Hi Paul,
>>>>
>>>> This is the GS presentation on PDF. This documents is covered under the signed NDA.
>>>>
>>>> Regards,
>>>>
>>>> Gonzalo
>> <2014.02.11 American Well Materials[1].pdf